مباشر
Lonza NewsSmall-Molecule CDMO Outlook: What Lies Ahead - DCAT Value Chain InsightsClinical OMICsPioneering Innovation in Transplant DiagnosticsFierceBiotechRoche nabs EU approval on label expansions for companion dx platformFierceBiotechGenentech executes another round of layoffs, with 3 VPs axedScienceLaser-boosted microscopes could reveal new drug targets, sharpen views inside cellsScienceThe ocean current that warms Europe may be more resilient than fearedClinical OMICsCyclana Bio Is Exploring the Extracellular Matrix to Treat EndometriosisFierceBiotechAI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data findsRoche MediaGenentech executes another round of layoffs, with 3 VPs axed - Fierce BiotechClinical OMICsHigher Vitamin C Levels in Blood Linked to Healthier Aging BrainsClinical OMICsStopping Neurodegeneration in Place with VaccinesClinical OMICsRemote Monitoring Benefits Unclear After Hospitalization for Serious Infection
BioWorld ٢٢ ديسمبر ٢٠٢٥

Aché Laboratórios Farmacêuticos describes new SGLT-1, SGLT-2 and DPP4 inhibitors

Aché Laboratórios Farmacêuticos describes new SGLT-1, SGLT-2 and DPP4 inhibitors

المصدر
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.